Panacea Biotec Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Panacea Biotec Limited has submitted a compliance certificate for Q4 FY2026 (ending March 31, 2026) as required under SEBI regulations. The certificate, issued by Skyline Financial Services Private Limited (the company's Registrar and Transfer Agent), confirms that physical share certificates received for dematerialization were properly processed. It certifies that these securities are listed on the stock exchange and that the physical certificates have been mutilated and cancelled, with the depository substituted as registered owner within the mandated 15-day period.
This is a routine regulatory compliance filing with no material impact on shareholders or stock price. It simply confirms the company followed proper dematerialization procedures during the quarter.